Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 AND POTASSIUM CHLORIDE 0 075 versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 AND POTASSIUM CHLORIDE 0 075 versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 5% provides a source of carbohydrates and calories to restore blood glucose levels and correct dehydration. Potassium chloride replenishes potassium ions, which are essential for maintaining cellular membrane potential, nerve impulse transmission, and muscle contraction. The combination corrects hypokalemia and prevents potassium depletion during intravenous fluid therapy.
Dextrose provides a source of calories and energy by entering the glycolytic pathway and being metabolized to carbon dioxide and water. Potassium chloride replenishes potassium ions, which are essential for nerve impulse conduction, muscle contraction, and maintaining intracellular osmotic pressure.
Intravenous infusion: 500-1000 mL at a rate of 100-200 mL/hour, not exceeding 25 mEq potassium per hour (or 0.5 mEq/kg/hour) and a maximum concentration of 40 mEq/L. Total daily dose depends on fluid and electrolyte needs.
Intravenous infusion of potassium chloride 0.3% in dextrose 5% at a rate determined by potassium deficit and patient tolerance, typically 10-20 mEq per hour; maximum infusion rate 40 mEq/hour in non-emergency situations.
None Documented
None Documented
Dextrose: not applicable (endogenous); potassium: 12-24 hours (distribution half-life), terminal phase not defined due to homeostatic regulation.
Not applicable as a single drug; potassium's terminal half-life ~12-24 hours (depends on total body stores and renal function); dextrose half-life ~15-20 minutes (highly variable with insulin response). Clinical context: half-life relevant only for potassium monitoring in renal impairment.
Renal: Potassium excreted primarily via kidneys (90%) with some fecal loss; dextrose is metabolized to CO2 and water, excreted renally as water and bicarbonate (less than 5% unchanged).
Potassium: >90% renal excretion. Dextrose: metabolized to CO2 and water; no significant renal excretion of intact glucose unless hyperglycemia exceeds renal threshold.
Category C
Category C
IV Fluid
IV Fluid